Our trustees

Nicola Mumford – Chair of Trustees

Trustee Nicola MumfordNicola Mumford is a Non-Executive Director at Harbour Litigation Funding the UK’s largest funder of commercial litigation and international arbitration, a Director at Wragge, Lawrence Graham & Co where she supports the board on its gender diversity program.  Before taking on gender diversity Nicola’s expertise was as a litigation lawyer dealing with international and high profile cases. The influential Chambers UK directory noted her ‘… completely uncompromising approach to client care.’   Nicola was the first woman chair of the International Bar Association’s Litigation Committee and formerly Wragge & Co’s London Managing Partner.

Outside her interests in the law, Nicola is the Principal of jewellery house Edith and Kiveen www.edithandkiveen.co.uk which she set up having identified a gap in the market for affordable bespoke jewellery following years of experience as a consumer and providing advice to her colleagues on the perfect gift!

Nicola’s connection with Pancreatic Cancer Action is as a result of her Father being one of the very few and very lucky survivors of the disease having been diagnosed in 2000 and still going strong!

Phil Stunt – Founding Trustee

Trustee Phil StuntPhil Stunt is the Senior Vice President Operations and Technology for First Data’s international businesses, and long suffering husband of our CEO and Founder, Ali Stunt.

Phil is responsible for overseeing First Data’s technology and operations across Europe, Middle East and Africa as well as the Asian geographies. He is tasked with transforming the delivery of First Data’s solutions for electronic payments.

Prior to joining First Data in December 2009, Phil spent five years working for Computer Associates, where he was responsible for running the internal infrastructure outside of North America.

Phil is a Non Executive Director of Molten Consulting, a transformational change consultancy specialising in the energy sector.

Earlier in his career, he was an Associate Partner at Accenture, focusing on transformational IT and supply chain initiatives within the communications and high-tech sector. Phil began his career with Royal Dutch Shell, working in a variety of downstream oil engineering, trading and operations roles in places including Australia, Saudi Arabia, Germany and the UK.

Phil attended the Loughborough University of Technology (UK) earning BSc in physics and electronic engineering.

Mr Neville Menezes – Founding Trustee and Consultant HPB surgeon

Trustee Neville MenezesMr Neville Menezes is a Consultant Pancreatico-biliary Surgeon and is one of the founder members and Trustees of Pancreatic Cancer Action. He is one of the medical advisors on the panel of doctors for ‘ Pancreatic Cancer Action’. He is appointed as the Consultant HPB Surgeon for the Surrey, West Sussex and Hampshire Cancer network holding Consultant posts at The Royal Surrey County Hospital NHS Foundation Trust in Guildford and Ashford & St. Peter’s Hospital NHS Foundation Trust in Chertsey Surrey.

His specialist surgical training was in the West of Scotland & The South Thames Deanery. He completed his FRCS from The Royal College of Surgeons, Edinburgh and thereafter pursued research & specialist training followed by an Intercollegiate FRCS (Gen. Surg.) in 2002.

His Pancreatico-biliary experience and research related to minimally invasive techniques for intractable pancreatic pain was acquired at the Lister Department of Surgery at the Glasgow Royal Infirmary working with Professor CW Imrie and his Hepatobiliary experience was acquired at King’s College Hospital in London. His Laparoscopic Training was at the Minimal Access Therapeutic Training Unit (MATTU) in Guildford.

He strongly believes that any improvement in pancreatic cancer survival will be related to and as a direct consequence of early diagnosis which is also the primary aim of our charity ‘Pancreatic Cancer Action’.

He is a great advocate of on-site cytology during ERCP & EUS diagnostic techniques and offers it to all his patients diagnosed with pancreatic and biliary cancers.

Alex Fulton – Trustee

Trustee Alex FultonAlex Fulton is Head of Communications for National Services at the NSPCC.  She is responsible for raising awareness of the NSPCC’s wide range of universal services to children, adults and professionals including ChildLine Services, the main NSPCC helpline, child protection information services and its training and consultancy safeguarding programmes for professionals and organisations.  These services form a vital, authoritative and integral part of the child protection system.  She reports to Alison Jeremy, Director Communications and Peter Watt, Director of National Services.

She joined the NSPCC after 10 years at the BBC in a range of public service, commercial and international roles.  She  was most recently Head of Communications for TV Sales, Content and Production at BBC Worldwide. Previous roles included Senior Communications Manager for BBC Worldwide Americas in New York and Digital Communications Manager, with responsibility for launching the global BBC iPlayer and BBC.com.  She began her BBC career in 2002 after four years at independent PR agency Richmond Towers.

Stephen Krag – Trustee

Stephen Krag is Chief Financial Officer for the European Operations of the Royal Bank of Canada (RBC), based in London. He is a member of the European Operating Committee and a director of a number of RBC subsidiaries including RBC Europe Ltd and BlueBay Asset Management.

Stephen joined RBC in 2011 and earlier in his career he worked for a number of other financial institutions including NatWest Markets, HBOS and Daiwa Capital Markets in various finance and operational roles.  He is a graduate of Cambridge University and is a qualified chartered accountant.

Stephen was appointed a trustee of Pancreatic Cancer Action on 11th April 2017 and chairs the Finance Committee.

Hugh Goodfellow – Trustee

I lead the Life Sciences team at a leading firm of patent attorneys in London. In that role, I spend much of my time overseeing teams of specialists who assist innovator companies in developing and protecting novel clinical products. These companies range from large and long-established global companies through to smaller European biotech companies. My particular area of current focus includes biologics – in particular, therapeutic antibodies, complex immunological therapies like CAR-T, and stem cells. I received my degree in Biochemistry and DPhil in Molecular Medicine from the University of Oxford. My experience at the bench was spent investigating mechanisms of drug resistance in cancer cells.

Outside of work, I am an adrenaline junkie and spend much of my spare time trying to frighten my family and friends, sometimes also myself.

I became involved as a Trustee at Pancreatic Cancer Action following the death of a close friend from this awful disease. I hope to provide a link between the fund-raising activities of the charity and the process that decides how its funds can be spent most beneficially in line with the charity’s goals.